A round-up of news from Johns Hopkins Medicine for busy executives.
_________________________________________________________
Each year for the past 15 we've felt both privileged and humbled to be ranked at the top of U.S. News & World Report's Honor Roll of American hospitals. We know this designation is a tribute to the entire organization: our dedicated nurses and staff, the School of Medicine's faculty and community physicians, and our trustees whose behind-the-scenes contributions are so significant. What a wonderful acknowledgment of the innovative and compassionate care that is Johns Hopkins' hallmark. In this issue, you can read about that achievement, plus our collaboration with India's largest hospital group, the new members of our board of trustees, treating enlarged hearts with "Viagra," and Stroke Center designation for Hopkins Hospital and Hopkins Bayview Medical Center. Research reports highlight cervical precancers that disappear in some women and a study that may help scientists regenerate damaged nerves. We welcome your suggestions and hope you enjoy reading these reports. -- Edward D. Miller, M.D., Dean of the Medical Faculty, CEO, Johns Hopkins Medicine
-- Ronald R. Peterson, President, Johns Hopkins Health System, The Johns Hopkins Hospital
THE BUSINESS OF MEDICINE
HOPKINS HOSPITAL TOPS 'U.S.NEWS' RANKINGS FOR 15TH STRAIGHT YEAR
U.S. News & World Report's ranking of top American medical centers again rates The Johns Hopkins Hospital No. 1 overall, as well as in Ear, Nose & Throat; Gynecology; Kidney Disease; Rheumatology, and Urology. Hopkins also was in the top four nationwide in Ophthalmology, Geriatrics, Neurology/Neurosurgery, Cancer, Digestive Disorders, Heart/Heart Surgery, Hormonal Disorders, Pediatrics, Psychiatry, Respiratory Disorders and Orthopedics.SEVEN MEMBERS JOIN HOPKINS MEDICINE BOARD OF TRUSTEES
A collateral descendant of Johns Hopkins, Liza Bailey (Credit Suisse First Boston), is elected to the institution's board along with Robert C. Baker (National Realty & Development Corp.), Baltimore lawyer Rick Berndt, Phil Butterfield (Bank of Bermuda), Richard Forsythe (Forsythe Technology) and Ed Gillespie (Quinn Gillespie and Associates). HOPKINS COLLABORATES WITH ASIA'S LARGEST HOSPITAL GROUP
Johns Hopkins International and Apollo Hospitals Group form a partnership on continuing medical education programs; oncology, neurosciences and cardiology projects; nurse education; telemedicine, and second option services. Apollo owns or manages 35 hospitals in India and Asia.
PETERSON CONTINUES AS VICE-CHAIR OF MARYLAND HOSPITAL ASSOCIATION
Ronald Peterson, president of The Johns Hopkins Health System and The Johns Hopkins Hospital, wins election to another term as vice chair of the Maryland Hospital Association's Board after having served previously as CEO councillor-at-large and treasurer of MHA's Executive Committee.
SCIENCE REPORT
JHH, HOPKINS BAYVIEW GAIN 'STROKE CENTER' STATUS
The Joint Commission on Accreditation of Healthcare Organizations and the American Stroke Association certify Hopkins Hospital and Hopkins Bayview Medical Center as primary stroke centers based on their exceptional efforts to improve outcomes, experienced stroke specialists and superior nursing. FOR ENLARGED HEARTS, TAKE VIAGRA
Hopkins researchers find that sildenafil citrate, the erectile dysfunction drug known as Viagra, also effectively treats enlarged hearts in mice, stopping further muscle growth from occurring and reversing existing growth.RESEARCHERS UNCOVER CLUES TO 'DISAPPEARING' PRECANCERS
New studies shed light on why cervical precancers disappear in some women and not in others. This finding may provide better targets for developing a cervical cancer vaccine. UNRAVELING NERVE GROWTH MYSTERY THROUGH YOUNG TADPOLES
Scientists studying "pre-tadpole" frogs at Hopkins' Institute for Cell Engineering uncover the first link between two key biological factors guiding nerve growth, an important step toward regenerating damaged nerves.
COMMENTARY
BRODY'S UNCENSORED IDEA
Lowering the high cost of bringing a drug to market, and making the drug available in poor nations, could be achieved through a large, open-source network with huge clinical trials, writes University President Bill Brody.
Visit the Johns Hopkins Medicine site at:
http://www.hopkinsmedicine.org For news and information from The Johns Hopkins University:
http://www.alumni.jhu.edu/jhupdate
If you would like to subscribe to the e-mail version of JHUpdate, send an e-mail message to lyris@list.alumni.jhu.edu with the subject line "Subscribe JHUpdate." The e-mail address will be added to the list. Archive of Past Issues
|
